维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Simkens"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy显示文摘	Y.L.B. Klaver L.H.J. Simkens V.E.P.P. Lemmens M. Koopman S. Teerenstra R.P. Bleichrodt I.H.J.T. de Hingh C.J.A. Punt	2012	European Journal of Surgical Oncology2012，，7：	2
	2	Maintenance treatment with eapeeitabine and bevacizumab versus observation alter induction treat- ment with chemotherapy and bevacizumab in metastatic colorectal cancer(mCRC) :The phase III CAIRO3 stmty EEl the Dutch Cnloreetal Cancer Group (DCCG) 显示文摘	Koopman M Lieke HJ Simkens AJ	2013	J Clinical Oncol2013，，：	1
	3	Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer(mCRC): The phase III CAIR03 study of the Dutch Colorectal Cancer Group(DCCG)显示文摘	Koopman M Simkens LHT Tije AJT	2013	] Clin Oncol2013，，：	1
	4	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3) : a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group 显示文摘	SIMKENS L H VAN TINTEREN H MAY A	2015	Lancet2015，385，9980：	1
	5	Maintenance treatment with Capecitabine and Bevacizumab in metastatic eolorectal cancer (CAIRO3) : A phase 3 randomised controlled trial of the Dutch colorectal cancer group 显示文摘	Simkens LH van Tinteren H May A	2015	Lancet2015，385，9980：	1
	6	Maintenance treat- merit with capecitabine and bevacizumab in metastatic colorec- tal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group显示文摘	Simkens L H van Tinteren H May A	2015	Lancet2015，385，9980：	1
	7	Final results and subgroup analyses of the phase 3 CAIR03 study:Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer(mCRC)显示文摘	KOOPMAN M SIMKENS L MAY A	2014	J Clin Oncol2014，32，3：	1
	8	Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with Capeeitabine and Bevacizumab versus observation after induction treatment with chemotherapy and Bevacizumab in metastatic colorectal cancer (mCRC)显示文摘	Koopman M Simkens L May A	2014	J Clin Oncol2014，32，3：	1
	9	Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with Capecitabine + Bevacizumab versus observation after induction treatment with chemotherapy + Bevacizumab in metastatic colorectal cancer (mCRC)显示文摘	Koopman M Simkens L May AM	2014	J Clin Oncol2014，32，15：	1
	10	Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy显示文摘	KLAVER Y L SIMKENS L H LEMMENS V E	2012	Eur J Surg Oncol2012，38，7：	1
	11	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer(CAIR03):a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group显示文摘	Simkens LH Van Tinteren H May A	2015	Lancet2015，385，9980：	1
	12	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer(CAIRO3):a phase 3 randomized controlled trial of the Dutch Colorectal Cancer Group显示文摘	Simkens LH Van Tinteren H May A	2015	Lancet2015，385，9980：	1
	13	The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab 显示文摘	Simkens LH Tol J Terstappen LW	2010	Ann Oncol2010，21，12：	1
	14	Unsteadiness of breathing in patients with hyperventilation syndrome and anxiety disorders 显示文摘	Han JN Stegen K Simkens K	1997	Eur Respir J1997，10，1：	1
	15	Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer(mCRC):The phase Ⅲ CAIRO3 study of the Dutch Colorectal Canccr Group (DCCG)显示文摘	Miriam Koopman L Simkens A ten Tije	2013	J Clin Oncol2013，，：	1
	16	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer ( CAIRO3 ) : a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group 显示文摘	Simkens LH van Tinteren H May A	2015	Lancet2015，385，9980：	1
	17	Massive surgical emphysema following transanal endoscopic microsurgery显示文摘We describe an impressive and rare case of surgical emphysema after minimally invasive rectal surgery. This case reports on a patient who developed mas-sive retroperitoneal, intraperitoneal and subcutaneous emphysema directly following a transanal endoscopic microsurgery(TEM) procedure for a rectal intramuco-sal carcinoma. Free intra-abdominal air after gastro-intestinal surgery can be a sign of a bowel perforation or anastomotic leakage. This is a serious complication often requiring immediate surgery. In our patient an abdominal computed tomography-scan with rectal con-trast showed no signs of a rectal perforation. Therefore this emphysema was caused by the insufflation of CO2 gas in the rectum during the TEM-procedure. Conserva-tive treatment resulted in an uneventful recovery. With the increasing usage of TEM for rectal lesions we ex-pect this complication to occur more often. After ruling out a full thickness rectal wall perforation in patients with surgical emphysema following TEM, conservative treatment is the treatment of choice.	Geert AAM Simkens Simon W Nienhuijs Misha DP Luyer Ignace HJT de Hingh	2014	World Journal of Gastrointestinal Surgery2014，6，8：	1
	18	Final results and sub- group analyses of the phase 3 CAIRO3 study: maintenance treatment with capecitabine + bevacizumab versus observation after induction treatment with chemotherapy + bevacizumab in metastatic colorectal cancer (mCRC)显示文摘	Koopman M Simkens L May AM et at	2014	J Clin Oncol2014，32，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费